ERD

EJP RD | European Joint Programme on Rare Diseases

01-01-2019

-

31-08-2024

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

01-01-2017

-

30-06-2023

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

01-05-2023

-

30-04-2026

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

OPTIMA | Optimal treatment for patients with solid tumours in Europe through Artificial intelligence

01-10-2021

-

30-09-2026

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

PIONEER | Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

01-05-2018

-

31-10-2023

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

01-03-2019

-

31-08-2025

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

01-01-2023

-

31-12-2026

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

SISAQOL-IMI | Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

01-01-2021

-

31-12-2024

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

01-01-2017

-

31-12-2024

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

canSERV | Providing cutting edge cancer research services across Europe

01-09-2022

-

31-08-2025

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

STRONG-AYA | THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER

01-10-2022

-

30-09-2027

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)

01-10-2015

-

30-11-2020

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

HTx | Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe

01-01-2019

-

30-06-2024

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

STREXIT2 | A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA

01-06-2023

-

31-05-2028

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

DE-ESCALATE | INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL

01-06-2023

-

31-05-2028

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

LEGATO | Lomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study

01-06-2023

-

31-05-2028

Show more information

Organisation EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

Projects overview

Selected filters:

EJP RD | European Joint Programme on Rare Diseases

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

OPTIMA | Optimal treatment for patients with solid tumours in Europe through Artificial intelligence

PIONEER | Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

SISAQOL-IMI | Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

canSERV | Providing cutting edge cancer research services across Europe

STRONG-AYA | THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER

MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)

HTx | Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe

STREXIT2 | A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA

DE-ESCALATE | INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL

LEGATO | Lomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study